Atlas Trials

Evaluating the Impact of 18F-FDG-PET-CT on Risk Stratification and Treatment Adaptation for Patients with Muscle Invasive Bladder Cancer

Clinical trial NCT04724928 · RECRUITING

Trial details

NCT number
NCT04724928
Sponsor
University Hospital, Ghent
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Muscle-Invasive Bladder Carcinoma
Start date
2021-04-29
Primary completion
2029-12-31
Enrollment
156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.